Michael Severino's most recent trade in Viatris Inc was a trade of 25,112 Restricted Stock Units done . Disclosure was reported to the exchange on May 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viatris | Michael Severino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 25,112 | 25,112 | - | - | Restricted Stock Units | |
| Avantor Inc. | Michael Severino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 17,100 | 60,551 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc. | Michael Severino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 8,477 | 43,451 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc. | Michael Severino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 9,808 | 34,974 (0%) | 0% | 0 | Common Stock | |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 150.79 per share. | 23 May 2022 | 68,196 | 163,708 (0%) | 0% | 150.8 | 10,283,275 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 46,320 | 0 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 114.36 per share. | 23 May 2022 | 46,320 | 198,423 (0%) | 0% | 114.4 | 5,297,155 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 21,739 | 43,478 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 105.92 per share. | 23 May 2022 | 21,739 | 231,904 (0%) | 0% | 105.9 | 2,302,595 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 11,742 | 38,188 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.50 per share. | 23 May 2022 | 11,742 | 210,165 (0%) | 0% | 93.5 | 1,097,877 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 151.53 per share. | 23 May 2022 | 11,605 | 152,103 (0%) | 0% | 151.5 | 1,758,506 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2022 | 70,879 | 0 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.36 per share. | 16 May 2022 | 70,879 | 222,982 (0%) | 0% | 61.4 | 4,349,135 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.50 per share. | 16 May 2022 | 64,636 | 252,103 (0%) | 0% | 93.5 | 6,043,466 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2022 | 64,636 | 49,930 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 154.49 per share. | 16 May 2022 | 54,279 | 154,203 (0%) | 0% | 154.5 | 8,385,563 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 154.80 per share. | 16 May 2022 | 53,327 | 152,503 (0%) | 0% | 154.8 | 8,255,020 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 154.04 per share. | 16 May 2022 | 46,273 | 205,830 (0%) | 0% | 154.0 | 7,127,893 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 153.43 per share. | 16 May 2022 | 43,621 | 208,482 (0%) | 0% | 153.4 | 6,692,770 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.02 per share. | 16 May 2022 | 35,364 | 187,467 (0%) | 0% | 79.0 | 2,794,463 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2022 | 35,364 | 0 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2022 | 29,121 | 35,364 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.02 per share. | 16 May 2022 | 29,121 | 252,103 (0%) | 0% | 79.0 | 2,301,141 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 155.27 per share. | 16 May 2022 | 2,100 | 152,103 (0%) | 0% | 155.3 | 326,067 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 155.44 per share. | 16 May 2022 | 400 | 152,103 (0%) | 0% | 155.4 | 62,176 | Common Stock, $0.01 par value |
| Avantor Inc. | Michael Severino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 6,693 | 25,166 (0%) | 0% | 0 | Common Stock | |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.44 per share. | 06 May 2022 | 74,309 | 226,412 (0%) | 0% | 54.4 | 4,045,382 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 74,309 | 0 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.88 per share. | 06 May 2022 | 70,779 | 222,882 (0%) | 0% | 58.9 | 4,167,468 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 70,779 | 0 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.86 per share. | 06 May 2022 | 66,299 | 218,402 (0%) | 0% | 54.9 | 3,637,163 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 66,299 | 0 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 152.83 per share. | 06 May 2022 | 48,591 | 152,103 (0%) | 0% | 152.8 | 7,426,163 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 149.53 per share. | 06 May 2022 | 47,215 | 204,888 (0%) | 0% | 149.5 | 7,060,059 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 151.13 per share. | 06 May 2022 | 45,988 | 165,939 (0%) | 0% | 151.1 | 6,950,166 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 150.10 per share. | 06 May 2022 | 40,176 | 211,927 (0%) | 0% | 150.1 | 6,030,418 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.88 per share. | 06 May 2022 | 33,701 | 252,103 (0%) | 0% | 58.9 | 1,984,315 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 33,701 | 70,779 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 150.63 per share. | 06 May 2022 | 31,714 | 173,174 (0%) | 0% | 150.6 | 4,777,080 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.36 per share. | 06 May 2022 | 29,221 | 252,103 (0%) | 0% | 61.4 | 1,793,001 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 29,221 | 70,879 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 152.24 per share. | 06 May 2022 | 28,536 | 200,694 (0%) | 0% | 152.2 | 4,344,321 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.86 per share. | 06 May 2022 | 25,691 | 252,103 (0%) | 0% | 54.9 | 1,409,408 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 25,691 | 66,299 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 151.16 per share. | 06 May 2022 | 22,873 | 229,230 (0%) | 0% | 151.2 | 3,457,483 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 151.42 per share. | 06 May 2022 | 21,071 | 152,103 (0%) | 0% | 151.4 | 3,190,571 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 151.78 per share. | 06 May 2022 | 13,836 | 152,103 (0%) | 0% | 151.8 | 2,100,028 | Common Stock, $0.01 par value |
| Avantor Inc. | Michael Severino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 1,215 | 18,473 (0%) | 0% | 0 | Common Stock | |
| AbbVie | Michael Severino | Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 149.54 per share. | 25 Feb 2022 | 38,857 | 152,103 (0%) | 0% | 149.5 | 5,810,676 | Common Stock, $0.01 par value |
| AbbVie | Michael Severino | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 48,198 | 151,450 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Michael Severino | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 48,161 | 48,161 | - | - | Option (Right to Buy) | |
| AbbVie | Michael Severino | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 17,468 | 179,395 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Michael Severino | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 11,565 | 190,960 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Michael Severino | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 10,477 | 161,927 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Michael Severino | Vice Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Dec 2021 | 583 | 103,252 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Michael Severino | Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.74 per share. | 28 Feb 2021 | 29,077 | 103,835 (0%) | 0% | 107.7 | 3,132,756 | Common Stock, $0.01 par value |
| Avantor Inc. | Michael Severino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 7,236 | 17,258 (0%) | 0% | 0 | Common Stock | |
| AbbVie | Michael Severino | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 65,217 | 65,217 | - | - | Option(right to buy) | |
| AbbVie | Michael Severino | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 29,121 | 96,402 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Michael Severino | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 17,468 | 132,912 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Michael Severino | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 10,477 | 115,444 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Michael Severino | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 8,565 | 104,967 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Michael Severino | Vice Chairman | Sale of securities on an exchange or to another person at price $ 93.61 per share. | 04 Nov 2020 | 90,679 | 67,281 (0%) | 0% | 93.6 | 8,488,461 | Common Stock, $0.01 par value |